Kings Point Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $13.8M | Buy |
48,448
+1,639
| +4% | +$465K | 1.2% | 34 |
|
|
2021
Q4 | $17.6M | Buy |
46,809
+1,992
| +4% | +$751K | 1.44% | 24 |
|
|
2021
Q3 | $18.5M | Sell |
44,817
-13,357
| -23% | -$5.51M | 1.64% | 16 |
|
|
2021
Q2 | $21.5M | Sell |
58,174
-1,255
| -2% | -$464K | 1.95% | 9 |
|
|
2021
Q1 | $17.2M | Buy |
59,429
+240
| +0.4% | +$69.6K | 1.7% | 12 |
|
|
2020
Q4 | $14.8M | Sell |
59,189
-143
| -0.2% | -$35.7K | 1.58% | 13 |
|
|
2020
Q3 | $13.4M | Buy |
59,332
+1,720
| +3% | +$390K | 1.68% | 12 |
|
|
2020
Q2 | $10M | Buy |
57,612
+687
| +1% | +$120K | 1.46% | 19 |
|
|
2020
Q1 | $7.19M | Buy |
56,925
+29,407
| +107% | +$3.71M | 1.27% | 29 |
|
|
2019
Q4 | $4.2M | Buy |
27,518
+3,949
| +17% | +$603K | 0.62% | 56 |
|
|
2019
Q3 | $3.12M | Buy |
23,569
+23,492
| +30,509% | +$3.11M | 0.53% | 61 |
|
|
2019
Q2 | $11K | Buy |
+77
| New | +$11K | ﹤0.01% | 410 |
|